Stratagene Launches ArrayAssist(R) CopyNumber; Only Guided Workflow Available to Biologists for Copy Number Analysis; Entire ArrayAssist(R) Platform Earns GeneChip-Compatible(TM) Status With Affymetrix Platform.LA JOLLA La Jolla (lə hoi`yə), on the Pacific Ocean, S Calif., an uninc. district within the confines of San Diego; founded 1869. The beautiful ocean beaches, in particular La Jolla shores and Black's Beach, and sea-washed caves attract visitors and , Calif. -- Stratagene Corporation (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :STGN), a leading developer, manufacturer and marketer of specialized life science research and diagnostic products, today announced the launch of its ArrayAssist(R) Copy Number Software. This powerful yet extremely intuitive software Application programs that have a friendly interface and work like users would expect. Menu functions are available in a logical order that one finds natural. The most common functions are presented in one menu or are located at the top of the menu list rather than being buried in rigid is the only guided workflow presently available for copy number analysis, enabling researchers to easily manipulate and analyze the massive data sets generated by leading chromosomal copy number microarrays. The ArrayAssist Copy Number software is Stratagene's most recent application on the ArrayAssist platform, which includes ArrayAssist(R) Expression and ArrayAssist(R) Exon Exon In split genes, a portion that is included in the ribonucleic acid (RNA) transcript of a gene and survives processing of the RNA in the cell nucleus to become part of a spliced messenger RNA (mRNA) or structural RNA in the cell cytoplasm. , the latest versions of which were introduced in January 2006. All ArrayAssist applications have earned GeneChip-compatible(TM) status with the Affymetrix platform. They will soon be provided as universal binaries, able to run natively on the latest Intel-based Macintosh(R) computers, and are compatible with Mac(R) OS X, Windows(R), and Linux(R). "Our ArrayAssist platform is deliberately designed to make sophisticated, high-density array analysis accessible to the life scientist," said David Edwards David Edwards may refer to one of the following persons.
ArrayAssist Copy Number supports the identification of biomarkers for cancer, degenerative disease and developmental disorders by highlighting chromosomal amplifications and deletions. Biologists can compare their experimental data in ArrayAssist CopyNumber with a reference genome using ArrayAssist's integrated genome browser, a feature of all ArrayAssist applications, and map biological pathways for a comprehensive understanding of the relevant relationships in their system with the integration of Stratagene's PathwayArchitect(TM) platform. Stratagene will be demonstrating ArrayAssist Copy Number in Booth #6 at the Cambridge HealthTech Institute's Microarray Data Analysis and Interpretation conference, being held at the Ritz-Carlton in Washington D.C., from August 23 to 25, 2006. Stratagene's ArrayAssist and PathwayArchitect products suites are powered by the award-winning avadis(TM) technology and are co-developed with Strand Life Sciences. About ArrayAssist The ArrayAssist product suite provides easy to use, biology-focused workflows designed to process a wide variety of gene expression arrays, from raw .CEL CEL Cellular CEL Celestial CEL Check Engine Light CEL Degrees Celsius (temperature) CEL Comisión Ejecutiva Hidroeléctrica del Río Lempa (El Salvador) CEL Center for Entrepreneurial Leadership data through primary expression and quality analysis to advanced gene-level and exon-level analysis. It has a comprehensive suite of tools to examine both transcriptional and splicing splicing /splic·ing/ (spli´sing) 1. the attachment of individual DNA molecules to each other, as in the production of chimeric genes. 2. RNA s. regulation using the Affymetrix GeneChip arrays as well as advanced analytical features such as multi-way ANOVA anova see analysis of variance. ANOVA Analysis of variance, see there , non-parametric statistical tests, classifiers for machine learning-based prediction and sophisticated, interactive visualization options. The ArrayAssist Expression, ArrayAssist Exon, and ArrayAssist Copy Number products are fully integrated with Stratagene's PathwayArchitect systems biology pathway analysis software. About Stratagene Corporation Stratagene is a developer, manufacturer and marketer of specialized life science research and diagnostic products. The Company's life science research unit supports advances in science by inventing, manufacturing and distributing products that simplify, accelerate and improve research. These products are used throughout the academic, industrial and government research sectors in fields spanning molecular biology molecular biology, scientific study of the molecular basis of life processes, including cellular respiration, excretion, and reproduction. The term molecular biology was coined in 1938 by Warren Weaver, then director of the natural sciences program at the Rockefeller , genomics, proteomics, drug discovery and toxicology. The Company's diagnostic unit develops and manufactures products for urinalysis, and high quality automated instrument and reagent systems that use blood samples to test for more than 1,000 different allergies and autoimmune disorders Autoimmune Disorders Definition Autoimmune disorders are conditions in which a person's immune system attacks the body's own cells, causing tissue destruction. . In addition, by combining its expertise in diagnostics and molecular biology, as well as its experience with FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. regulatory procedures, the Company is pursuing opportunities to expand its product portfolio to include molecular diagnostic kits and instrumentation. More information is available at http://www.stratagene.com. Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. Statement Certain statements in this news release that are not historical fact constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Stockholders and other readers are cautioned not to place undue reliance on these forward-looking statements. Stratagene generally identifies forward-looking statements by using words like "believe," "intend," "target," "expect," "estimate," "may," "should," "plan," "project," "contemplate," "anticipate," "predict" or similar expressions. You can also identify forward-looking statements by discussions of strategies, plans or intentions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results of Stratagene to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Among the important factors that could cause actual results to differ materially from those contained in or implied by the forward-looking statements are risks associated with the company's inability to sufficiently anticipate market needs and develop products and product enhancements that achieve market acceptance, including molecular diagnostic testing Diagnostic testing Testing performed to determine if someone is affected with a particular disease. Mentioned in: Von Willebrand Disease kits and related products, the company's ability to compete effectively in the diagnostics and life sciences research markets, variability of the company's quarterly revenues and operating results, the failure of the company to retain key employees, the company's ability to obtain additional debt or equity financing Equity Financing The act of raising money for company activities by selling common or preferred stock to individual or institutional investors. In return for the money paid, shareholders receive ownership interests in the corporation. , the possibility of declining sales due in part to a reduction in research and development budgets or government funding, the company's ongoing ability to protect its own intellectual property rights and to avoid violating the intellectual property rights of third parties, extended manufacturing difficulties and currency fluctuations. For more information about these and other factors that could cause actual results to differ materially from those contained in or implied by the forward-looking statements please see "Factors that May Affect Future Results" included in Stratagene's Annual Report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. for the year ended December 31, 2004 and in other reports filed by Stratagene from time to time with the Securities and Exchange Commission, including Quarterly Reports on Form 10-Q Form 10-Q See 10-Q. . NOTE: Affymetrix, the Affymetrix logo, and GeneChip are registered trademarks owned or used by Affymetrix Inc. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion